The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2020 Apr 15

PMID 32285272

Citations 1

Affiliations

Soon will be listed here.

Abstract

The Chicago Consensus Working Group provides multidisciplinary recommendations for palliative care specifically related to peritoneal surface malignancies. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.

Citing Articles

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond.

Mangieri C, Levine E Front Oncol. 2022; 12:992030.

PMID: 36425565 PMC: 9679779. DOI: 10.3389/fonc.2022.992030.

References

Clark K, Lam L, Currow D . Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?. Support Care Cancer. 2009; 17(12):1463-8. DOI: 10.1007/s00520-009-0609-3. View

De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V . Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage. 1991; 6(8):484-6. DOI: 10.1016/0885-3924(91)90005-o. View

Peng X, Wang P, Li S, Zhang G, Hu S . Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer. World J Surg Oncol. 2015; 13:50. PMC: 4372044. DOI: 10.1186/s12957-015-0455-3. View

Mittal D, Mittal A, Brosnan E, Landman W . Nonopioid pharmacological management of malignant bowel obstruction: a New Zealand-wide survey. J Palliat Med. 2014; 17(11):1249-55. DOI: 10.1089/jpm.2014.0176. View

Feuer D, Broadley K, Shepherd J, Barton D . Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000; (4):CD002764. DOI: 10.1002/14651858.CD002764. View

Minoura T, Takeuchi M, Morita T, Kawakami K . Practice Patterns of Medications for Patients With Malignant Bowel Obstruction Using a Nationwide Claims Database and the Association Between Treatment Outcomes and Concomitant Use of H-Blockers/Proton Pump Inhibitors and Corticosteroids With.... J Pain Symptom Manage. 2017; 55(2):413-419.e2. DOI: 10.1016/j.jpainsymman.2017.10.019. View

Currow D, Quinn S, Agar M, Fazekas B, Hardy J, McCaffrey N . Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage. 2014; 49(5):814-21. DOI: 10.1016/j.jpainsymman.2014.09.013. View

Khoo D, Hall E, Motson R, Riley J, Denman K, Waxman J . Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer. 1994; 30A(1):28-30. DOI: 10.1016/s0959-8049(05)80012-7. View

Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M . Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol. 2010; 40(8):739-45. DOI: 10.1093/jjco/hyq048. View

10.

Shima Y, Ohtsu A, Shirao K, Sasaki Y . Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Jpn J Clin Oncol. 2008; 38(5):354-9. DOI: 10.1093/jjco/hyn035. View

11.

Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A . Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage. 2000; 19(1):23-34. DOI: 10.1016/s0885-3924(99)00147-5. View

12.

Matulonis U, Seiden M, Roche M, Krasner C, Fuller A, Atkinson T . Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage. 2005; 30(6):563-9. DOI: 10.1016/j.jpainsymman.2005.05.018. View

13.

Herman L, Hoskins W, Shike M . Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel. Gastrointest Endosc. 1992; 38(3):314-8. DOI: 10.1016/s0016-5107(92)70423-4. View

14.

Pothuri B, Montemarano M, Gerardi M, Shike M, Ben-Porat L, Sabbatini P . Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol. 2005; 96(2):330-4. DOI: 10.1016/j.ygyno.2004.09.058. View

15.

Kawata N, Kakushima N, Tanaka M, Sawai H, Imai K, Hagiwara T . Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction. Dig Endosc. 2013; 26(2):208-13. DOI: 10.1111/den.12139. View

16.

Issaka R, Shapiro D, Parikh N, Mulcahy M, Komanduri S, Martin J . Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction. Surg Endosc. 2013; 28(5):1668-73. DOI: 10.1007/s00464-013-3368-7. View

17.

Vashi P, Dahlk S, Vashi R, Gupta D . Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction. Eur J Gastroenterol Hepatol. 2011; 23(11):1069-73. DOI: 10.1097/MEG.0b013e32834b0e2a. View

18.

Dittrich A, Schubert B, Kramer M, Lenz F, Kast K, Schuler U . Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction. Support Care Cancer. 2017; 25(9):2849-2856. DOI: 10.1007/s00520-017-3700-1. View

19.

Zucchi E, Fornasarig M, Martella L, Maiero S, Lucia E, Borsatti E . Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study. Support Care Cancer. 2016; 24(7):2877-82. DOI: 10.1007/s00520-016-3102-9. View

20.

Pinard K, Goring T, Egan B, Koo D . Drainage Percutaneous Endoscopic Gastrostomy for Malignant Bowel Obstruction in Gastrointestinal Cancers: Prognosis and Implications for Timing of Palliative Intervention. J Palliat Med. 2017; 20(7):774-778. PMC: 8349727. DOI: 10.1089/jpm.2016.0465. View